Weight-Loss Drug Zepbound May Work Better in Women Than Men
THURSDAY, Sept. 12, 2024 (HealthDay News) — The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the clinical trials that led to its approval. All doses of tirzepatide consistently reduced weight in both women and men, researchers found. ButContinue Reading